A randomized trial demonstrates improved exercise tolerance in patients with chronic heart failure, suggesting beneficial effects on quality of life.
YQFM has remarkable efficacy in enhancing the exercise tolerance and quality of life of patients with CHF, as well as improving their cardiac function. It also has good safety profiles.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: